As one of the richest countries in the world, the United States is compared with other developed countries on a variety of measures. It is well-known that on a per capita basis we almost certainly have the highest health care spending in the world. It is often pointed out that despite that high spending, on a number of measures our quality of care and our health is not that good, with one common measure being life expectancy at birth. This argument regarding poor comparative outcomes is used to justify calls for changes to the system. A Health Affairs article summarizes research that demonstrates that the analysis is not that simple; that an indicator such as life expectancy is seriously misleading if various adjustments for other factors are not made. (HA Article) In 2007, a newly born American male could expect to live 75.6 years and a female for 80.8, both very low among seventeen high-income countries. The issue, however, is almost exclusively found among age cohorts below 50 years of age. In cohorts above that, the United States actually is almost the best performer. And why do younger people die more in this country than in others? The primary differential causes are noncommunicable diseases, like heart disease, which likely are due to poor diet and exercise regimens, homicides for males, transport injuries, i.e., car accidents, and non-transport injuries, like drug overdoses. In other words, we don’t take good care of ourselves and we are careless. Our health system may not be the greatest, but it is really our culture which is responsible for what appears to be the poor performance of our health system, and the behavior resulting from that culture is likely one of the primary drivers of our high spending.
Life Expectancy in the United States
By Kevin RocheMarch 26, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…
March 24, 2023
A Couple of Health Care Notes
A couple of pieces of health care research focus on high health care spending and…